We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.48B
AUM Growth
+$119M
(+5%)
Cap. Flow
+$158M
Cap. Flow
% of AUM
6.35%
Top 10 Holdings %
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
190
Avg Time Held Equity + Options
2.6
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
2.1
years
Avg Time Held Equity only
2.6
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$24.8M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$24.7M |
| 3 |
iShares Core US REIT ETF
USRT
|
+$23.7M |
| 4 |
Coupang
CPNG
|
+$22M |
| 5 |
FTOC
FTAC Olympus Acquisition Corp. Class A Ordinary Shares
FTOC
|
+$15.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Medical Devices ETF
IHI
|
+$15.9M |
| 2 |
iShares Global Tech ETF
IXN
|
+$14.7M |
| 3 |
iShares US Treasury Bond ETF
GOVT
|
+$9.94M |
| 4 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$3.22M |
| 5 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$2.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.99% |
| 2 | Technology | 15.91% |
| 3 | Financials | 8.1% |
| 4 | Healthcare | 5.94% |
| 5 | Consumer Discretionary | 5.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2926
Saic
SAIC
$5.59B
| $1K | ﹤0.01% |
+12
| New | +$1.03K |
2021 Q3
0 quarters
|
|
2927
Filana Therapeutics
FLNA
$36.8M
| $1K | ﹤0.01% |
20
| – | – |
2021 Q1
2 quarters
|
|
2928
DELISTED
Steelcase
SCS
| $1K | ﹤0.01% |
48
-96
| -67% | -$1.32K |
2021 Q1
2 quarters
|
|
2929
Champion Homes
SKY
$4.34B
| $1K | ﹤0.01% |
+10
| New | +$592 |
2021 Q3
0 quarters
|
|
2930
Solid Biosciences
SLDB
$615M
| $1K | ﹤0.01% |
+19
| New | +$807 |
2021 Q3
0 quarters
|
|
2931
SelectQuote
SLQT
$60.9M
| $1K | ﹤0.01% |
+66
| New | +$994 |
2021 Q3
0 quarters
|
|
2932
Simply Good Foods
SMPL
$985M
| $1K | ﹤0.01% |
36
| – | – |
2021 Q1
2 quarters
|
|
2933
Faeth Therapeutics
FTH
$532M
| $1K | ﹤0.01% |
+3
| New | +$546 |
2021 Q3
0 quarters
|
|
2934
Sohu.com
SOHU
$329M
| $1K | ﹤0.01% |
35
+33
| +1,650% | +$705 |
2021 Q2
1 quarter
|
|
2935
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$18.3B
| $1K | ﹤0.01% |
25
| – | – |
2021 Q2
1 quarter
|
|
2936
Scholar Rock
SRRK
$4.95B
| $1K | ﹤0.01% |
+19
| New | +$665 |
2021 Q3
0 quarters
|
|
2937
DELISTED
Stellar Bancorp
STEL
| $1K | ﹤0.01% |
50
| – | – |
2020 Q1
6 quarters
|
|
2938
DELISTED
Sitio Royalties
STR
| $1K | ﹤0.01% |
54
-43
| -44% | -$802 |
2020 Q1
6 quarters
|
|
2939
Tarsus Pharmaceuticals
TARS
$3.32B
| $1K | ﹤0.01% |
+44
| New | +$1.09K |
2021 Q3
0 quarters
|
|
2940
DELISTED
Triumph Group
TGI
| $1K | ﹤0.01% |
64
+19
| +42% | +$354 |
2021 Q2
1 quarter
|
|
2941
Thor Industries
THO
$3.61B
| $1K | ﹤0.01% |
9
-11
| -55% | -$1.26K |
2021 Q1
2 quarters
|
|
2942
Interface
TILE
$2.08B
| $1K | ﹤0.01% |
55
| – | – |
2021 Q1
2 quarters
|
|
2943
Turning Point Brands
TPB
$1.21B
| $1K | ﹤0.01% |
25
| – | – |
2020 Q3
4 quarters
|
|
2944
DELISTED
TPI Composites
TPIC
| $1K | ﹤0.01% |
38
-27
| -42% | -$1.06K |
2021 Q1
2 quarters
|
|
2945
Texas Pacific Land
TPL
$23.9B
| $1K | ﹤0.01% |
+9
| New | +$1.4K |
2021 Q3
0 quarters
|
|
2946
Tower Semiconductor
TSEM
$23.7B
| $1K | ﹤0.01% |
+23
| New | +$662 |
2021 Q3
0 quarters
|
|
2947
Sixth Street Specialty
TSLX
$1.68B
| $1K | ﹤0.01% |
58
+22
| +61% | +$504 |
2021 Q1
2 quarters
|
|
2948
10x Genomics
TXG
$9.43B
| $1K | ﹤0.01% |
10
-1
| -9% | -$172 |
2020 Q4
3 quarters
|
|
2949
UFP Technologies
UFPT
$2.3B
| $1K | ﹤0.01% |
+19
| New | +$1.2K |
2021 Q3
0 quarters
|
|
2950
UroGen Pharma
URGN
$1.79B
| $1K | ﹤0.01% |
47
| – | – |
2020 Q2
5 quarters
|
|
Similar funds
Parallel Advisors's Q3 2021 Portfolio in Review
As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Parallel Advisors deployed $158M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
By sector, the portfolio is most concentrated in Miscellaneous at 52% of assets, down from 53% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.
- Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
- Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
- Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
- Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
- Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
- Parallel Advisors opened 363 new positions and closed 190 in Q3 2021.
- Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.
Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.